The global Humanized Mouse Model Market is witnessing significant growth due to increasing investments in biomedical research, rising demand for advanced preclinical testing, and expanding applications in oncology, immunology, infectious disease research, and drug discovery. Humanized mouse models are genetically engineered to mimic human biological systems, enabling researchers to study disease mechanisms and evaluate the safety and efficacy of new therapies before clinical trials. Growing adoption of precision medicine and advances in genetic engineering technologies are further driving market expansion.

According to Fortune Business Insights, The humanized mouse model market size was valued at USD 0.28 billion in 2025. The market is projected to grow from USD 0.31 billion in 2026 to USD 0.58 billion by 2034, exhibiting a CAGR of 8.34 % during the forecast period.

Why is the Humanized Mouse Model Market Growing?

The increasing need for predictive preclinical research models is one of the primary factors driving the Humanized Mouse Model Market. Pharmaceutical companies, biotechnology firms, and academic institutions are increasingly utilizing humanized mouse models to improve drug discovery, reduce clinical trial failures, and accelerate the development of targeted therapies.

Rapid advancements in CRISPR gene-editing technology, immuno-oncology research, regenerative medicine, and personalized healthcare are further accelerating market growth. Growing investments in translational research and increasing collaborations between research institutions and pharmaceutical companies are also creating significant growth opportunities.

Humanized mouse models are widely used for:

• Oncology research
• Immunology studies
• Infectious disease research
• Drug discovery and development
• Toxicology testing
• Personalized medicine
• Regenerative medicine
• Vaccine development

Growing investments in life sciences research and precision medicine continue to create substantial opportunities for market participants.

Key Market Trends Shaping Industry Growth

Rising Adoption in Immuno-Oncology Research

Researchers are increasingly using humanized mouse models to evaluate cancer immunotherapies, immune checkpoint inhibitors, and targeted therapies before clinical testing.

Growing Integration of CRISPR Gene-Editing Technologies

Advanced gene-editing technologies are improving the development of highly accurate humanized mouse models, enabling more reliable disease modeling and therapeutic evaluation.